Cases
Representative Matters: Represented the shareholder in the negotiation, documentation
closing of the sale of his stock to an acquisition subsidiary owned by the ultimate parent La Financiere Atalian S.A.S, a French company, a leading international provider of facility services operating in 31 countries.
Represented K&M Associates, a leader in US fashion accessories, in the acquisition of 100% of the stock of MJM Jewelry Corp., d/b/a Berry Jewelry.
Represented Quest Diagnostics, Inc. in the acquisition of the assets of the outreach laboratory business of Cape Care Healthcare, Inc., which operates numerous outpatient centers throughout Cape Cod, including Cape Cod Hospital
Falmouth Hospital.
Represented private equity firm Clarion Capital Partners
its portfolio company Lenox Corporation in Lenox's successful $22.2 million bid in the US Bankruptcy Court for the District of Massachusetts to acquire, in a Section 363 sale, substantially all of the assets of Reed
Barton Corporation, a prominent American silversmith manufacturer.
Represented The Pediatric Physician's Group at Children's, Inc., the community-based physicians organization affiliated with the Boston Children's Hospital, in a restructuring
entity formation to exp
the community-based doctors group.
Represented Quest Diagnostics (NYSE: DGX) in the acquisition of ConVerge Diagnostic Services, a New Engl
based diagnostic laboratory.
Represented Quest Diagnostics (NYSE: DGX) in a series of acquisitions of the outreach clinical laboratory
anatomic pathology businesses of UMass Memorial in Massachusetts
New Engl
.
Represented Systagenix Wound Management LTD in the sale of a biologic product line to Healthpoint.
Represented Systagenix Wound Management LTD in various acquisitions
licensing transactions of intellectual property
/or medical devices in the field of wound management, as well as in product development, distribution
supply arrangements in the US
Europe.
Represented Wright Medical Technology Inc. in the acquisition of an orthopedic ankle system from a Netherl
s based owner
manufacturer, including post acquisition European manufacturing
distribution agreements.
Represented London Stock Exchange chemical company in its asset acquisition of two generic pharmaceutical companies.
Represented an UK based financial software company in multiple software licensing
maintenance agreements to national investment banks
brokerage firms.
Represented US/Russian based custom software developer in multiple software licensing
maintenance agreements
its sale to large Russian software company.
Represented an institutional pharmaceutical company in the sale of the company to an American Stock Exchange listed corporation, for shares of the acquiring company.
Represented Elkem ASA, a Norwegian based energy
minerals company in technology licensing
development transactions with fortune 100 company, as well as early stage development agreements.
Represented the majority stockholder of Syms Corp. in connection with a rights offering, backstop agreement,
stock redemption in connection with the reorganization of Syms Corp.
Filene's Basement in Chapter 11 Bankruptcy proceedings.
Represented a New Engl
based regional bank in its purchase of revenue bonds from Massachusetts Development Finance Agency
subsequent loan to a large non-profit charity in connection with the acquisition
redevelopment of a number of its facilities.
Represented Versa Capital Management in its acquisitions of Plymouth Rubber Company
Malden Mills in reorganization proceedings under Chapter 11 of the Bankruptcy Code.
Represented Archway
Mother's Cookie Companies in Chapter 363 sales of their assets in reorganization proceedings under Chapter 11 of the Bankruptcy Code.
Represented the developer of a large mixed use retail, condominium
hotel development in its project acquisition
structuring,
the negotiation
documentation of multiple rounds of financing from a syndicate of banks in excess of $275 million.
Represented a number of professional service firms, CPA, law,
engineering, in multiple acquisitions, entity formations
restructurings.
Represented Somerset Therapeutics in the negotiation
preparation of all documents regarding a sale of Somerset as well as certain individuals in their capacity as controlling shareholders in the sale by Wintac Limited in the Business Transfer Agreement of its assets.
